174 related articles for article (PubMed ID: 11709349)
1. Outbreak of cefozopran (penicillin, oral cephems, and aztreonam)-resistant Neisseria gonorrhoeae in Japan.
Muratani T; Akasaka S; Kobayashi T; Yamada Y; Inatomi H; Takahashi K; Matsumoto T
Antimicrob Agents Chemother; 2001 Dec; 45(12):3603-6. PubMed ID: 11709349
[TBL] [Abstract][Full Text] [Related]
2. Emergence of cephem- and aztreonam-high-resistant Neisseria gonorrhoeae that does not produce beta-lactamase.
Akasaka S; Muratani T; Yamada Y; Inatomi H; Takahashi K; Matsumoto T
J Infect Chemother; 2001 Mar; 7(1):49-50. PubMed ID: 11406757
[TBL] [Abstract][Full Text] [Related]
3. Emergence of a Neisseria gonorrhoeae clone showing decreased susceptibility to cefixime in England and Wales.
Chisholm SA; Alexander S; Desouza-Thomas L; Maclure-Webster E; Anderson J; Nichols T; Lowndes CM; Ison CA;
J Antimicrob Chemother; 2011 Nov; 66(11):2509-12. PubMed ID: 21846672
[TBL] [Abstract][Full Text] [Related]
4. Molecular characterization of two high-level ceftriaxone-resistant Neisseria gonorrhoeae isolates detected in Catalonia, Spain.
Cámara J; Serra J; Ayats J; Bastida T; Carnicer-Pont D; Andreu A; Ardanuy C
J Antimicrob Chemother; 2012 Aug; 67(8):1858-60. PubMed ID: 22566592
[TBL] [Abstract][Full Text] [Related]
5. Cephalosporin-resistant gonorrhea: it's just a matter of time.
Deresinski S
AIDS Alert; 2011 Oct; 26(10):115-6. PubMed ID: 22096785
[No Abstract] [Full Text] [Related]
6. High Prevalence of Azithromycin-Resistant Neisseria gonorrhoeae Isolates With a Multidrug Resistance Phenotype in Fukuoka, Japan.
Tanaka M; Furuya R; Irie S; Kanayama A; Kobayashi I
Sex Transm Dis; 2015 Jun; 42(6):337-41. PubMed ID: 25970312
[TBL] [Abstract][Full Text] [Related]
7. Susceptibility pattern of Neisseria gonorrhoeae to antimicrobial agents in Dar es Salaam.
Mbwana J; Mhalu F; Mwakagile D; Masesa J; Moshiro C; Sandstrom E
East Afr Med J; 1999 Jun; 76(6):330-4. PubMed ID: 10750520
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial susceptibility and genotypic distribution of Neisseria gonorrhoeae: a 2-year study in Tunisia.
Ferjani A; Marzouk M; Saghrouni F; Hadj Ali M; Boukadida J
Med Mal Infect; 2013 May; 43(5):211-2. PubMed ID: 23623306
[No Abstract] [Full Text] [Related]
9. [The monitoring of Neisseria gonorrhoeae infection incidence and its resistance in Suceava County].
Filipiuc S; Nicolae O; Luncă C; Iancu LS
Rev Med Chir Soc Med Nat Iasi; 2009; 113(4):1238-42. PubMed ID: 20191906
[TBL] [Abstract][Full Text] [Related]
10. Antibiotic resistant N. gonorrhoeae in Trinidad and Tobago.
Castor D; Prabhakar P; Furlonge C; Rao A; Brown A; Camara B; Weiss H; Jolly PE
Cell Mol Biol (Noisy-le-grand); 2001 Sep; 47(6):987-95. PubMed ID: 11785665
[TBL] [Abstract][Full Text] [Related]
11. The influence of target population on nonculture-based detection of markers of Neisseria gonorrhoeae antimicrobial resistance.
Goire N; Freeman K; Lambert SB; Nimmo GR; Limnios AE; Lahra MM; Nissen MD; Sloots TP; Whiley DM
Sex Health; 2012 Nov; 9(5):422-9. PubMed ID: 23036167
[TBL] [Abstract][Full Text] [Related]
12. Neisseria gonorrhoeae and emerging resistance to extended spectrum cephalosporins.
Tapsall JW
Curr Opin Infect Dis; 2009 Feb; 22(1):87-91. PubMed ID: 19532086
[TBL] [Abstract][Full Text] [Related]
13. Emergence and spread of Neisseria gonorrhoeae clinical isolates harboring mosaic-like structure of penicillin-binding protein 2 in Central Japan.
Ito M; Deguchi T; Mizutani KS; Yasuda M; Yokoi S; Ito S; Takahashi Y; Ishihara S; Kawamura Y; Ezaki T
Antimicrob Agents Chemother; 2005 Jan; 49(1):137-43. PubMed ID: 15616287
[TBL] [Abstract][Full Text] [Related]
14. Increasing prevalence of penicillinase-producing Neisseria gonorrhoeae and the emergence of high-level, plasmid-mediated tetracycline resistance among gonococcal isolates in The Gambia.
Adegbola RA; Sabally S; Corrah T; West B; Mabey D
Trop Med Int Health; 1997 May; 2(5):428-32. PubMed ID: 9217698
[TBL] [Abstract][Full Text] [Related]
15. Survey on antibiotic sensitivity of Neisseria gonorrhoeae strains isolated in China, 1987-1992.
Ye SZ
Sex Transm Dis; 1994; 21(4):237-40. PubMed ID: 7974078
[TBL] [Abstract][Full Text] [Related]
16. [Aztreonam, a new approach in the therapy of gonorrhea].
Stöberl C; Poitschek C; Söltz-Szöts J
Wien Klin Wochenschr; 1991; 103(9):271-3. PubMed ID: 1906213
[TBL] [Abstract][Full Text] [Related]
17. Activity of faropenem tested against Neisseria gonorrhoeae isolates including fluoroquinolone-resistant strains.
Jones RN; Critchley IA; Whittington WL; Janjic N; Pottumarthy S
Diagn Microbiol Infect Dis; 2005 Dec; 53(4):311-7. PubMed ID: 16269221
[TBL] [Abstract][Full Text] [Related]
18. Cluster of multidrug-resistant Neisseria gonorrhoeae with reduced susceptibility to the newer cephalosporins in Northern Greece.
Tzelepi E; Daniilidou M; Miriagou V; Siatravani E; Pavlidou E; Flemetakis A
J Antimicrob Chemother; 2008 Sep; 62(3):637-9. PubMed ID: 18556708
[No Abstract] [Full Text] [Related]
19. [Neisseria gonorrhoeae infections].
Furuya R; Tanaka M
Nihon Rinsho; 2009 Jan; 67(1):129-35. PubMed ID: 19177762
[TBL] [Abstract][Full Text] [Related]
20. Quinolone resistance-determining region mutations and por type of Neisseria gonorrhoeae isolates: resistance surveillance and typing by molecular methodologies.
Giles JA; Falconio J; Yuenger JD; Zenilman JM; Dan M; Bash MC
J Infect Dis; 2004 Jun; 189(11):2085-93. PubMed ID: 15143477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
